Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,600
Closed -$394K 3850
2020
Q4
$394K Sell
3,600
-900
-20% -$97.8K ﹤0.01% 3300
2020
Q3
$490K Sell
4,500
-100
-2% -$10.1K ﹤0.01% 3129
2020
Q2
$419K Hold
4,600
﹤0.01% 3214
2020
Q1
$363K Sell
4,600
-800
-15% -$66.8K ﹤0.01% 3187
2019
Q4
$468K Hold
5,400
﹤0.01% 3275
2019
Q3
$452K Buy
5,400
+400
+8% +$34K ﹤0.01% 3288
2019
Q2
$420K Buy
5,000
+1,700
+52% +$134K ﹤0.01% 3380
2019
Q1
$264K Buy
3,300
+2,700
+450% +$201K ﹤0.01% 3537
2018
Q4
$43K Buy
+600
New +$42.2K ﹤0.01% 3703

Other funds holding ABT

Invesco's ABT Position: Q2 2026 in Review

Invesco reduced its Abbott (ABT) stake by 11% in Q2 2026, selling an estimated $94.6M and leaving 8,817,240 shares worth $800M. The position accounts for 0.06% of the portfolio, ranked #231.

Invesco first reported a position in ABT in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.87B in Q3 2025. 2,975 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Invesco held 8,817,240 shares of Abbott worth $800M as of Q2 2026.
  • Invesco sold 1,036,363 Abbott shares in Q2 2026, an estimated $94.6M.
  • Abbott made up 0.06% of Invesco's portfolio in Q2 2026, its #231 holding.
  • Invesco first reported a position in Abbott in Q2 2013 and has held it in 53 quarters since.
  • Invesco's Abbott position peaked at $1.87B in Q3 2025.
  • 2,975 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.